ABBVIE INC (1ABBV.MI) Stock Fundamental Analysis
Europe - Euronext Milan - BIT:1ABBV - US00287Y1091 - Common Stock
188 EUR
-1.6 (-0.84%)
Taking everything into account, 1ABBV scores 5 out of 10 in our fundamental rating. 1ABBV was compared to 86 industry peers in the Biotechnology industry. There are concerns on the financial health of 1ABBV while its profitability can be described as average. 1ABBV has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
- 1ABBV had positive earnings in the past year.
- In the past year 1ABBV had a positive cash flow from operations.
- 1ABBV had positive earnings in each of the past 5 years.
- Each year in the past 5 years 1ABBV had a positive operating cash flow.
1.2 Ratios
- 1ABBV's Return On Assets of 1.75% is fine compared to the rest of the industry. 1ABBV outperforms 74.42% of its industry peers.
- 1ABBV's Return On Invested Capital of 15.64% is amongst the best of the industry. 1ABBV outperforms 93.02% of its industry peers.
- Measured over the past 3 years, the Average Return On Invested Capital for 1ABBV is above the industry average of 11.58%.
- The 3 year average ROIC (13.67%) for 1ABBV is below the current ROIC(15.64%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.75% | ||
| ROE | N/A | ||
| ROIC | 15.64% |
ROA(3y)5.07%
ROA(5y)5.21%
ROE(3y)80.76%
ROE(5y)70.31%
ROIC(3y)13.67%
ROIC(5y)12.68%
1.3 Margins
- 1ABBV has a Profit Margin of 3.94%. This is in the better half of the industry: 1ABBV outperforms 76.74% of its industry peers.
- In the last couple of years the Profit Margin of 1ABBV has declined.
- With an excellent Operating Margin value of 33.05%, 1ABBV belongs to the best of the industry, outperforming 88.37% of the companies in the same industry.
- In the last couple of years the Operating Margin of 1ABBV has declined.
- The Gross Margin of 1ABBV (71.16%) is better than 61.63% of its industry peers.
- 1ABBV's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 33.05% | ||
| PM (TTM) | 3.94% | ||
| GM | 71.16% |
OM growth 3Y-5.46%
OM growth 5Y-6.52%
PM growth 3Y-28.3%
PM growth 5Y-20.42%
GM growth 3Y0.39%
GM growth 5Y-1.92%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), 1ABBV is creating value.
- Compared to 1 year ago, 1ABBV has about the same amount of shares outstanding.
- 1ABBV has more shares outstanding than it did 5 years ago.
- 1ABBV has a worse debt/assets ratio than last year.
2.2 Solvency
- 1ABBV has an Altman-Z score of 2.38. This is not the best score and indicates that 1ABBV is in the grey zone with still only limited risk for bankruptcy at the moment.
- 1ABBV has a Altman-Z score of 2.38. This is in the better half of the industry: 1ABBV outperforms 70.93% of its industry peers.
- The Debt to FCF ratio of 1ABBV is 3.49, which is a good value as it means it would take 1ABBV, 3.49 years of fcf income to pay off all of its debts.
- The Debt to FCF ratio of 1ABBV (3.49) is better than 81.40% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 3.49 | ||
| Altman-Z | 2.38 |
ROIC/WACC1.85
WACC8.43%
2.3 Liquidity
- A Current Ratio of 0.72 indicates that 1ABBV may have some problems paying its short term obligations.
- 1ABBV has a Current ratio of 0.72. This is in the lower half of the industry: 1ABBV underperforms 77.91% of its industry peers.
- A Quick Ratio of 0.60 indicates that 1ABBV may have some problems paying its short term obligations.
- 1ABBV has a worse Quick ratio (0.60) than 77.91% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.72 | ||
| Quick Ratio | 0.6 |
3. Growth
3.1 Past
- The earnings per share for 1ABBV have decreased strongly by -12.09% in the last year.
- The Earnings Per Share has been growing slightly by 2.51% on average over the past years.
- 1ABBV shows a small growth in Revenue. In the last year, the Revenue has grown by 7.40%.
- 1ABBV shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.11% yearly.
EPS 1Y (TTM)-12.09%
EPS 3Y-7.24%
EPS 5Y2.51%
EPS Q2Q%-38%
Revenue 1Y (TTM)7.4%
Revenue growth 3Y0.08%
Revenue growth 5Y11.11%
Sales Q2Q%9.1%
3.2 Future
- The Earnings Per Share is expected to grow by 13.67% on average over the next years. This is quite good.
- Based on estimates for the next years, 1ABBV will show a small growth in Revenue. The Revenue will grow by 7.50% on average per year.
EPS Next Y7.3%
EPS Next 2Y19.85%
EPS Next 3Y16.87%
EPS Next 5Y13.67%
Revenue Next Year8.74%
Revenue Next 2Y9.15%
Revenue Next 3Y8.74%
Revenue Next 5Y7.5%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
- 1ABBV is valuated rather expensively with a Price/Earnings ratio of 23.12.
- 81.40% of the companies in the same industry are more expensive than 1ABBV, based on the Price/Earnings ratio.
- 1ABBV is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.38, which is the current average of the S&P500 Index.
- Based on the Price/Forward Earnings ratio of 15.03, the valuation of 1ABBV can be described as correct.
- Based on the Price/Forward Earnings ratio, 1ABBV is valued cheaply inside the industry as 88.37% of the companies are valued more expensively.
- Compared to an average S&P500 Price/Forward Earnings ratio of 24.29, 1ABBV is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 23.12 | ||
| Fwd PE | 15.03 |
4.2 Price Multiples
- 1ABBV's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. 1ABBV is cheaper than 77.91% of the companies in the same industry.
- Based on the Price/Free Cash Flow ratio, 1ABBV is valued cheaply inside the industry as 84.88% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 19.61 | ||
| EV/EBITDA | 15.92 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
- 1ABBV has a very decent profitability rating, which may justify a higher PE ratio.
- 1ABBV's earnings are expected to grow with 16.87% in the coming years. This may justify a more expensive valuation.
PEG (NY)3.17
PEG (5Y)9.21
EPS Next 2Y19.85%
EPS Next 3Y16.87%
5. Dividend
5.1 Amount
- 1ABBV has a Yearly Dividend Yield of 3.19%. Purely for dividend investing, there may be better candidates out there.
- Compared to an average industry Dividend Yield of 0.75, 1ABBV pays a better dividend. On top of this 1ABBV pays more dividend than 97.67% of the companies listed in the same industry.
- 1ABBV's Dividend Yield is rather good when compared to the S&P500 average which is at 1.84.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.19% |
5.2 History
- The dividend of 1ABBV is nicely growing with an annual growth rate of 7.72%!
Dividend Growth(5Y)7.72%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
- 1ABBV pays out 489.69% of its income as dividend. This is not a sustainable payout ratio.
- 1ABBV's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP489.69%
EPS Next 2Y19.85%
EPS Next 3Y16.87%
BIT:1ABBV (1/13/2026, 7:00:00 PM)
188
-1.6 (-0.84%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)10-31 2025-10-31/bmo
Earnings (Next)02-04 2026-02-04/amc
Inst Owners75.04%
Inst Owner ChangeN/A
Ins Owners0.05%
Ins Owner ChangeN/A
Market Cap332.27B
Revenue(TTM)59.64B
Net Income(TTM)2.35B
Analysts78.38
Price Target214.9 (14.31%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.19% |
Yearly Dividend5.38
Dividend Growth(5Y)7.72%
DP489.69%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1.85%
Min EPS beat(2)0.95%
Max EPS beat(2)2.75%
EPS beat(4)4
Avg EPS beat(4)1.21%
Min EPS beat(4)0.02%
Max EPS beat(4)2.75%
EPS beat(8)7
Avg EPS beat(8)0.95%
EPS beat(12)9
Avg EPS beat(12)0.65%
EPS beat(16)11
Avg EPS beat(16)0.49%
Revenue beat(2)1
Avg Revenue beat(2)-0.08%
Min Revenue beat(2)-0.79%
Max Revenue beat(2)0.63%
Revenue beat(4)2
Avg Revenue beat(4)0.22%
Min Revenue beat(4)-0.79%
Max Revenue beat(4)1.23%
Revenue beat(8)4
Avg Revenue beat(8)0.31%
Revenue beat(12)5
Avg Revenue beat(12)-0.17%
Revenue beat(16)5
Avg Revenue beat(16)-0.74%
PT rev (1m)0.67%
PT rev (3m)8.63%
EPS NQ rev (1m)-3.35%
EPS NQ rev (3m)-2.56%
EPS NY rev (1m)0.02%
EPS NY rev (3m)-11.46%
Revenue NQ rev (1m)-0.01%
Revenue NQ rev (3m)0.48%
Revenue NY rev (1m)0.01%
Revenue NY rev (3m)0.49%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 23.12 | ||
| Fwd PE | 15.03 | ||
| P/S | 6.47 | ||
| P/FCF | 19.61 | ||
| P/OCF | 18.5 | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | 15.92 |
EPS(TTM)8.13
EY4.32%
EPS(NY)12.51
Fwd EY6.66%
FCF(TTM)9.59
FCFY5.1%
OCF(TTM)10.16
OCFY5.4%
SpS29.05
BVpS-1.29
TBVpS-45.09
PEG (NY)3.17
PEG (5Y)9.21
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.75% | ||
| ROE | N/A | ||
| ROCE | 20.86% | ||
| ROIC | 15.64% | ||
| ROICexc | 16.59% | ||
| ROICexgc | 572.43% | ||
| OM | 33.05% | ||
| PM (TTM) | 3.94% | ||
| GM | 71.16% | ||
| FCFM | 33% |
ROA(3y)5.07%
ROA(5y)5.21%
ROE(3y)80.76%
ROE(5y)70.31%
ROIC(3y)13.67%
ROIC(5y)12.68%
ROICexc(3y)15.06%
ROICexc(5y)13.91%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)17.54%
ROCE(5y)16.27%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y-1.81%
ROICexc growth 5Y-14.87%
OM growth 3Y-5.46%
OM growth 5Y-6.52%
PM growth 3Y-28.3%
PM growth 5Y-20.42%
GM growth 3Y0.39%
GM growth 5Y-1.92%
F-Score7
Asset Turnover0.45
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 3.49 | ||
| Debt/EBITDA | 2.39 | ||
| Cap/Depr | 14.25% | ||
| Cap/Sales | 1.97% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 74.59% | ||
| Profit Quality | 838.33% | ||
| Current Ratio | 0.72 | ||
| Quick Ratio | 0.6 | ||
| Altman-Z | 2.38 |
F-Score7
WACC8.43%
ROIC/WACC1.85
Cap/Depr(3y)9.59%
Cap/Depr(5y)10.06%
Cap/Sales(3y)1.45%
Cap/Sales(5y)1.5%
Profit Quality(3y)361.43%
Profit Quality(5y)328.91%
High Growth Momentum
Growth
EPS 1Y (TTM)-12.09%
EPS 3Y-7.24%
EPS 5Y2.51%
EPS Q2Q%-38%
EPS Next Y7.3%
EPS Next 2Y19.85%
EPS Next 3Y16.87%
EPS Next 5Y13.67%
Revenue 1Y (TTM)7.4%
Revenue growth 3Y0.08%
Revenue growth 5Y11.11%
Sales Q2Q%9.1%
Revenue Next Year8.74%
Revenue Next 2Y9.15%
Revenue Next 3Y8.74%
Revenue Next 5Y7.5%
EBIT growth 1Y27.38%
EBIT growth 3Y-5.38%
EBIT growth 5Y3.87%
EBIT Next Year9.3%
EBIT Next 3Y15.61%
EBIT Next 5Y10.95%
FCF growth 1Y-20.4%
FCF growth 3Y-6.75%
FCF growth 5Y6.9%
OCF growth 1Y-18.24%
OCF growth 3Y-6.19%
OCF growth 5Y7.14%
ABBVIE INC / 1ABBV.MI FAQ
Can you provide the ChartMill fundamental rating for ABBVIE INC?
ChartMill assigns a fundamental rating of 5 / 10 to 1ABBV.MI.
What is the valuation status of ABBVIE INC (1ABBV.MI) stock?
ChartMill assigns a valuation rating of 6 / 10 to ABBVIE INC (1ABBV.MI). This can be considered as Fairly Valued.
What is the profitability of 1ABBV stock?
ABBVIE INC (1ABBV.MI) has a profitability rating of 6 / 10.
What is the valuation of ABBVIE INC based on its PE and PB ratios?
The Price/Earnings (PE) ratio for ABBVIE INC (1ABBV.MI) is 23.12 and the Price/Book (PB) ratio is -146.1.
Can you provide the dividend sustainability for 1ABBV stock?
The dividend rating of ABBVIE INC (1ABBV.MI) is 6 / 10 and the dividend payout ratio is 489.69%.